SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-19-009702
Filing Date
2019-05-29
Accepted
2019-05-29 13:48:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d052919xu_xynomic.htm SC 13D 52687
  Complete submission text file 0001213900-19-009702.txt   54272
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90028 | Film No.: 19860953
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 3306, K. WAH CENTRE 1010 MIDDLE HUAIHAI ROAD SHANGHAI F4 200031
Business Address
Xu Yinglin Mark (Filed by) CIK: 0001774080 (see all company filings)

Type: SC 13D